0001382101-18-000002.txt : 20180606
0001382101-18-000002.hdr.sgml : 20180606
20180606155042
ACCESSION NUMBER: 0001382101-18-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20180606
DATE AS OF CHANGE: 20180606
EFFECTIVENESS DATE: 20180606
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUTRO BIOPHARMA INC
CENTRAL INDEX KEY: 0001382101
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-314024
FILM NUMBER: 18883795
BUSINESS ADDRESS:
STREET 1: 310 UTAH AVE., #150
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-392-8412
MAIL ADDRESS:
STREET 1: 310 UTAH AVE., #150
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
D
1
primary_doc.xml
X0708
D
LIVE
0001382101
SUTRO BIOPHARMA INC
310 UTAH AVE., #150
SOUTH SAN FRANCISCO
CA
CALIFORNIA
94080
650-392-8412
DELAWARE
None
None
Corporation
true
William
J.
Newell
c/o Sutro Biopharma, Inc.
310 Utah Avenue, Suite 150
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
Director
Daniel
Janney
c/o Sutro Biopharma, Inc.
310 Utah Avenue, Suite 150
South San Francisco
CA
CALIFORNIA
94080
Director
John
G.
Freund
c/o Sutro Biopharma, Inc.
310 Utah Avenue, Suite 150
South San Francisco
CA
CALIFORNIA
94080
Director
Bryan
Lawlis
c/o Sutro Biopharma, Inc.
310 Utah Avenue, Suite 150
South San Francisco
CA
CALIFORNIA
94080
Director
Joseph
Lobacki
c/o Sutro Biopharma, Inc.
310 Utah Avenue, Suite 150
South San Francisco
CA
CALIFORNIA
94080
Director
Michael
Ross
c/o Sutro Biopharma, Inc.
310 Utah Avenue, Suite 150
South San Francisco
CA
CALIFORNIA
94080
Director
Armen
Shanafelt
c/o Sutro Biopharma, Inc.
310 Utah Avenue, Suite 150
South San Francisco
CA
CALIFORNIA
94080
Director
Biotechnology
Decline to Disclose
- 06b
false
2018-05-24
false
true
false
0
60000000
31624999
28375001
false
8
0
0
0
false
SUTRO BIOPHARMA INC
/s/ William J. Newell
William J. Newell
Chief Executive Officer
2018-06-06